Low rate of Clostridium difficile colonization in ambulatory and hospitalized HIV-infected patients in a hospital unit: A prospective survey

Journal of Infection

Volumn 37, Issue 2, 1998, Pages 108-111

  Mainardi, J L ^a   Lacassin, F ^b   Guilloy, Y ^b   Goldstein, F W ^a   Leport, C ^b   Acar, J F ^a   Vilde J L ^b  

^a SAINT JOSEPH HOSPITAL   (France)

^b BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN;

AMBULATORY CARE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CARRIER; BACTERIUM CULTURE; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOTOXICITY; DISEASE TRANSMISSION; FECES ANALYSIS; FEMALE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LATEX AGGLUTINATION TEST; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; UNIVERSITY HOSPITAL;

EID: 0031789392     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(98)80162-X     Document Type: Article

References (18)

1. Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Eng J Med 1978; 298: 531-534.
2. Viscidi R, Willey S, Bartlett JG. Isolation rates and toxigenic potential of Clostridium difficile isolates from various populations. Gastroenterology 1981; 81: 5-9.
3. Laughon BE, Druckman DA, Vernon A et al. Prevalence of enteric pathogens in homosexual men with and without acquired immunodeficiency syndrome. Gastroenterology 1988; 94: 984-993.
4. Bonnefoy A, Popoff MR. Prévalence des diarrhées à Clostridium difficile dans un groupe de sujets VIH-positifs. Med Mal Infect 1992; 22: 9-13.
5. Brosgart C, Bramble K, Barett T, Jacobson S, Swartzberg J, Bresnik M. Clostridium difficile colitis in adult HIV disease (Abstract 480). In: Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy (Anaheim, CA). Washington, DC: American Society for Microbiology, 1992.
6. Harrison KS, Bartlett JG. Clostridium difficile diarrhea in AIDS patients (Abstract 547). In: Program and abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago, IL). Washington. DC: American Society for Microbiology, 1991.
7. Hutin Y, Molina JM, Casin I et al. Risk factors for Clostridium difficile-associated diarrhoea in HIV-infected patients. AIDS 1993; 7 1441-1447.
8. McFarland LV, Mulligan ME, Kwok RYY, Stamm WE. Nosocomial acquisition of Clostridium difficile associated infection. N Engl J Med 1989; 320: 204-210.
9. Siegel DL, Edelstein PH, Nachamkin I. Inappropriate testing for diarrheal disease in the hospital. JAMA 1990: 263: 979-982.
10. Johnson S, Homann SR, Bettin KM et al. Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. Ann Intern Med 1992; 117: 297-302.
11. George WL, Sutter VL, Citron D, Finegold SM. Selective and differential medium for isolation of Clostridium difficile. J Clin Microbiol 1979; 9: 144-149.
12. Bartlett JG. Antibiotic-associated diarrhea. Clin Infect Dis 1992; 15: 573-581.
13. McFarland LV. Surawicz CM, Stamm WE. Risk factors for Clostridium difficile carriage and Clostridium difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis 1990; 162: 678-684.
14. Bartlett JG. Clostridium difficile: clinical considerations. Rev Infect Dis 1990; 12(Suppl. 2): S43-S51.
15. McFarland LV, Stamm WE. Review of Clostridium difficile-associated disease. Am J Infect Control 1986; 14: 99-109.
16. Barbut F, Mario N. Meyohas MC, Binet D. Frottier J, Petit JC. Investigation of a nosocomial outbreak of Clostridium difficile-associated diarrhoea among AIDS patients by random amplified polymorphic DNA (RAPD) assay. J Hosp Infect 1994; 26: 181-189.
17. Hughes JM, Jarvis WR. Nosocomial gastrointestinal infections. In: Wenzel RP, eds. Prevention and Control of Nosocomial Infections. Baltimore, MD: Williams & Wilkins. 1987; 405-439.
18. De Lalla F. Nicolin R, Rinaldi E et al. Prospective study of oral teicoplanin versus oral vancomycin for therapy of pseudomembranous colitis and Clostridium difficile-associated diarrhea. Antimicrob Agents Chemother 1992; 36: 2192-2196.